223 related articles for article (PubMed ID: 32849795)
21. Prognostic Value of miRNAs in Head and Neck Cancers: A Comprehensive Systematic and Meta-Analysis.
Kumarasamy C; Madhav MR; Sabarimurugan S; Krishnan S; Baxi S; Gupta A; Gothandam KM; Jayaraj R
Cells; 2019 Jul; 8(8):. PubMed ID: 31349668
[TBL] [Abstract][Full Text] [Related]
22. Identification of a sixteen-microRNA signature as prognostic biomarker for stage II and III colon cancer.
Jacob H; Stanisavljevic L; Storli KE; Hestetun KE; Dahl O; Myklebust MP
Oncotarget; 2017 Oct; 8(50):87837-87847. PubMed ID: 29152124
[TBL] [Abstract][Full Text] [Related]
23. miRNA profiling identifies deregulated miRNAs associated with osteosarcoma development and time to metastasis in two large cohorts.
Andersen GB; Knudsen A; Hager H; Hansen LL; Tost J
Mol Oncol; 2018 Jan; 12(1):114-131. PubMed ID: 29120535
[TBL] [Abstract][Full Text] [Related]
24. Prognostic value of microRNAs in lung cancer: A systematic review and meta-analysis.
Xiao W; Zhong Y; Wu L; Yang D; Ye S; Zhang M
Mol Clin Oncol; 2019 Jan; 10(1):67-77. PubMed ID: 30655979
[TBL] [Abstract][Full Text] [Related]
25. Abnormally expressed long non-coding RNAs in prognosis of Osteosarcoma: A systematic review and meta-analysis.
Chen D; Wang H; Zhang M; Jiang S; Zhou C; Fang B; Chen P
J Bone Oncol; 2018 Nov; 13():76-90. PubMed ID: 30591861
[TBL] [Abstract][Full Text] [Related]
26. Integrative data mining and meta-analysis to investigate the prognostic role of microRNA-200 family in various human malignant neoplasms: A consideration on heterogeneity.
Yuan L; Bing Z; Yan P; Li R; Wang C; Sun X; Yang J; Shi X; Zhang Y; Yang K
Gene; 2019 Oct; 716():144025. PubMed ID: 31394177
[TBL] [Abstract][Full Text] [Related]
27. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.
Zhang Y; Sui J; Shen X; Li C; Yao W; Hong W; Peng H; Pu Y; Yin L; Liang G
Oncol Rep; 2017 Jun; 37(6):3543-3553. PubMed ID: 28498428
[TBL] [Abstract][Full Text] [Related]
28. Pooling-analysis for diagnostic and prognostic value of MiRNA-100 in various cancers.
Dou Z; Lin S; Dai C; Lu Y; Tian T; Wang M; Liu X; Zheng Y; Xu P; Li S; Sheng Q; Deng Y; Dai Z
Oncotarget; 2017 Sep; 8(37):62703-62715. PubMed ID: 28977982
[TBL] [Abstract][Full Text] [Related]
29. Prognostic Value of MiRNAs in Patients with Laryngeal Cancer: A Systematic Review and Meta-Analysis.
Zou W; Hu X; Wang D; Jiang L
Curr Cancer Drug Targets; 2020; 20(10):802-810. PubMed ID: 32767932
[TBL] [Abstract][Full Text] [Related]
30. Clinicopathologic significance and prognostic value of circRNAs in osteosarcoma: a systematic review and meta-analysis.
Zhong J; Zhang G; Yao W
J Orthop Surg Res; 2021 Oct; 16(1):578. PubMed ID: 34620208
[TBL] [Abstract][Full Text] [Related]
31. Prognostic Value of MicroRNAs in Esophageal Carcinoma: A Meta-Analysis.
Gao S; Zhao ZY; Zhang ZY; Zhang Y; Wu R
Clin Transl Gastroenterol; 2018 Nov; 9(11):203. PubMed ID: 30420592
[TBL] [Abstract][Full Text] [Related]
32. Prognostic Value of Programmed Cell Death 1 Ligand-1 (PD-L1) or PD-1 Expression in Patients with Osteosarcoma: A Meta-Analysis.
Huang X; Zhang W; Zhang Z; Shi D; Wu F; Zhong B; Shao Z
J Cancer; 2018; 9(14):2525-2531. PubMed ID: 30026851
[No Abstract] [Full Text] [Related]
33. Prognostic value of candidate microRNAs in gastric cancer: A validation study.
Zhang L; Huang Z; Zhang H; Zhu M; Zhu W; Zhou X; Liu P
Cancer Biomark; 2017; 18(3):221-230. PubMed ID: 27983528
[TBL] [Abstract][Full Text] [Related]
34. Prognostic and Clinicopathological Value of Rac1 in Cancer Survival: Evidence from a Meta-Analysis.
Lou S; Wang P; Yang J; Ma J; Liu C; Zhou M
J Cancer; 2018; 9(14):2571-2579. PubMed ID: 30026856
[No Abstract] [Full Text] [Related]
35. Circulating MicroRNAs as Prognostic Molecular Biomarkers in Human Head and Neck Cancer: A Systematic Review and Meta-Analysis.
Lamichhane SR; Thachil T; Gee H; Milic N
Dis Markers; 2019; 2019():8632018. PubMed ID: 31827646
[TBL] [Abstract][Full Text] [Related]
36. Cytokines as Prognostic Biomarkers in Osteosarcoma Patients: A Systematic Review and Meta-analysis.
Liu G; Liu B; Liu B; Tang L; Liu Z; Dai H
J Interferon Cytokine Res; 2023 Aug; 43(8):335-343. PubMed ID: 37566475
[TBL] [Abstract][Full Text] [Related]
37. The diagnostic effect of serum miR-139-5p as an indicator in osteosarcoma.
Zhou L; Ma X; Yue J; Chen T; Wang XY; Wang ZW; Pan J; Lin Y
Cancer Biomark; 2018; 23(4):561-567. PubMed ID: 30347602
[TBL] [Abstract][Full Text] [Related]
38. Prognostic Role of Circulating miRNAs in Early-Stage Non-Small Cell Lung Cancer.
Ulivi P; Petracci E; Marisi G; Baglivo S; Chiari R; Billi M; Canale M; Pasini L; Racanicchi S; Vagheggini A; Delmonte A; Mariotti M; Ludovini V; Bonafè M; Crinò L; Grignani F
J Clin Med; 2019 Jan; 8(2):. PubMed ID: 30678026
[TBL] [Abstract][Full Text] [Related]
39. A comprehensive analysis for associations between multiple microRNAs and prognosis of osteosarcoma patients.
Yang W; Qi YB; Si M; Hou Y; Nie L
PeerJ; 2020; 8():e8389. PubMed ID: 31998559
[TBL] [Abstract][Full Text] [Related]
40. Prognostic value of microRNAs in pancreatic cancer: a meta-analysis.
Zhao F; Wei C; Cui MY; Xia QQ; Wang SB; Zhang Y
Aging (Albany NY); 2020 May; 12(10):9380-9404. PubMed ID: 32420903
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
